Univest
Univest
  • Markets

Top Mid-Cap Hospital Stocks Compared: Rainbow Children vs HCG vs Jupiter Life Line vs KIMS vs Narayana Hrudayalaya on Price, Valuation, Q2 FY27 Results and Risks

  • November 17, 2026
  • Posted by: Ankit Jaiswal
  • Category: Best Stocks
No Comments
Top Mid-Cap Hospital Stocks Compared: Rainbow Children vs HCG vs Jupiter Life Line vs KIMS vs Narayana Hrudayalaya on Price, Valuation, Q2 FY27 Results and Risks

Previous close: Rainbow Children Rs 1,276.80, HealthCare Global Rs 568.20, Jupiter Life Line Rs 289.90, KIMS Rs 763.35, Narayana Hrudayalaya Rs 1,895.30.

Quick Answer

This mid-cap hospital stocks compared snapshot checks five names on price, valuation and Q2 FY27 results: Rainbow Children, HealthCare Global, Jupiter Life Line, KIMS and Narayana Hrudayalaya. Narayana Hrudayalaya is the largest by market capitalisation at Rs 37,565 crore. Narayana Hrudayalaya reports the highest return on equity at 17.17%. Mid-cap hospital companies differ in speciality and region, so read each multiple next to margins and returns.

Mid-cap hospital stocks compared here means Rainbow Children, HealthCare Global, Jupiter Life Line, KIMS and Narayana Hrudayalaya on one page, checked on previous close, market value, valuation and the latest quarterly numbers. The group covers a children and women care chain, a cancer care chain, a multi-speciality hospital operator in western India, a southern regional chain and a heart and multi-speciality network, so each name serves a different patient base, which is exactly why a side-by-side look helps.

All five companies have filed their September 2026 quarter, so every result below is Q2 FY27. Mid-cap hospital stocks follow occupancy, bed additions and insurance coverage, so a glance at the Nifty Midcap 100 page and the Sensex page before you read the tables gives useful backdrop.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Mid-Cap Hospital Stocks Compared: Five Names on the List
  • Mid-Cap Hospital Stocks Valuation: Multiples, Returns and Payouts
  • Mid-Cap Hospital Stocks Q2 FY27 Results: Revenue and Profit Check
    • Rainbow Children Results Snapshot
    • HealthCare Global Results Snapshot
    • Jupiter Life Line Results Snapshot
    • KIMS Results Snapshot
    • Narayana Hrudayalaya Results Snapshot
  • Mid-Cap Hospital Stocks Compared Two at a Time: Three Pairings
    • Rainbow Children vs HealthCare Global
    • KIMS vs Narayana Hrudayalaya
    • Jupiter Life Line vs KIMS
  • Best Mid-Cap Hospital Stocks for Each Type of Investor
  • What Is Driving Mid-Cap Hospital Companies Right Now?
  • Risks to Weigh When You Compare Mid-Cap Hospital Stocks
  • How to Compare Mid-Cap Hospital Stocks and Build a Shortlist
  • Conclusion: Mid-Cap Hospital Stocks Compared at a Glance
  • Frequently Asked Questions on Mid-Cap Hospital Stocks Compared
    • Which are the top mid-cap hospital stocks compared in this article?
    • Which mid-cap hospital stock has the highest market capitalisation?
    • Which of these mid-cap hospital stocks has the lowest price to earnings ratio?
    • Which mid-cap hospital stock has the highest return on equity?
    • How did mid-cap hospital stocks perform in Q2 FY27 results?
    • What are the main risks when you compare mid-cap hospital stocks?
    • Which metrics matter most when you compare mid-cap hospital stocks?
    • Which is the best mid-cap hospital stock to buy among these five?

Mid-Cap Hospital Stocks Compared: Five Names on the List

The mid-cap hospital stocks compared here are Rainbow Children, HealthCare Global, Jupiter Life Line, KIMS and Narayana Hrudayalaya. Narayana Hrudayalaya is the largest by market capitalisation at Rs 37,565 crore. Previous closes run from Rs 289.90 for Jupiter Life Line to Rs 1,895.30 for Narayana Hrudayalaya, which is why a side-by-side look at value rather than price is more useful. This mid-cap hospital stocks compared list is the base for every table that follows.

Stock Previous close (Rs) Market cap (Rs crore)
Rainbow Children 1,276.80 13,136
HealthCare Global 568.20 8,589
Jupiter Life Line 289.90 9,353
KIMS 763.35 30,549
Narayana Hrudayalaya 1,895.30 37,565

A quick look at the business behind each ticker puts the numbers in context. Rainbow Children runs children and women care hospitals, while HealthCare Global runs cancer care centres. Jupiter Life Line runs multi-speciality hospitals in western India, and KIMS runs a regional hospital network. To compare mid-cap hospital stocks properly, line up price to earnings, return on equity and operating margin before forming a view.

Rounding out the group, Narayana Hrudayalaya runs heart care led hospitals. A fair mid-cap hospital stock comparison looks at what each company actually earns from, not only at the share price. A specialist chain and a multi-speciality network belong in separate mental boxes whenever you compare mid-cap hospital stocks fairly.

Mid-Cap Hospital Stocks Valuation: Multiples, Returns and Payouts

Narayana Hrudayalaya trades at the lowest price to earnings ratio in this group at 43.72. It also reports the highest return on equity at 17.17%. Jupiter Life Line has the lowest price to book value at 5.74. These mid-cap hospital stocks valuation readings come from the previous close and the latest reported financials. That is the idea behind this mid-cap hospital stocks compared table: price to earnings and return on equity sit side by side so a high or low reading stands out at once.

Stock Price to earnings Price to book ROE (%) Dividend yield (%) Debt to equity
Rainbow Children 44.00 7.66 17.05 0.27 0.56
HealthCare Global 394.01 6.37 4.25 1.19
Jupiter Life Line 50.14 5.74 11.43 0.07 0.41
KIMS 155.09 7.77 5.40 0.90
Narayana Hrudayalaya 43.72 7.51 17.17 0.24 1.21

Price to earnings, return on equity and debt to equity give the clearest picture, since expansion can add to borrowings at hospital chains. Earnings per share and book value per share are the building blocks behind price to earnings and price to book, so a glance at both in each filing is time well spent. A simple mid-cap hospital stock comparison like this one is only as useful as the context behind it, which is why operating margin is worth checking as well.

In this group, price to earnings runs from 43.72 for Narayana Hrudayalaya to 394.01 for HealthCare Global. Rainbow Children offers the highest dividend yield at 0.27%. For reference, the industry price to earnings sits at 62.11, so you can see at a glance which stocks are rated above or below the group. The industry price to earnings is a handy anchor: a stock above it is priced for faster growth, and one below it is priced for steadier earnings. A well-built mid-cap hospital stock comparison also notes that new beds take time to reach full occupancy. Run the same mid-cap hospital stock comparison on your own watchlist and the pattern in these numbers will be easier to spot.

Mid-Cap Hospital Stocks Q2 FY27 Results: Revenue and Profit Check

All of the five mid-cap hospital stocks compared have filed Q2 FY27 numbers. Narayana Hrudayalaya posted the fastest revenue growth at 73.6% year on year. Narayana Hrudayalaya showed the sharpest rise in net profit at 16.5%. Read revenue first and quarterly profit second, since the two together show how much of the growth reaches shareholders. Treat the Q2 FY27 numbers in this mid-cap hospital stocks compared review as a snapshot of one quarter, not a verdict on any hospital chain.

Stock Q2 FY27 revenue (Rs crore) Q2 FY26 revenue (Rs crore) Q2 FY27 net profit (Rs crore) Q2 FY26 net profit (Rs crore)
Rainbow Children 556.1 453.0 83.9 75.6
HealthCare Global 733.7 649.5
Jupiter Life Line 467.0 404.9
KIMS 1,363 964.9 74.6 72.0
Narayana Hrudayalaya 2,896 1,668 301.1 258.5

Rainbow Children Results Snapshot

Rainbow Children reported Q2 FY27 revenue of Rs 556.1 crore, compared with Rs 453.0 crore a year earlier, a rise of 22.8%. Net profit rose 10.9% to Rs 83.9 crore from Rs 75.6 crore. Earnings per share for the quarter rose to Rs 8.10 from Rs 7.41.

HealthCare Global Results Snapshot

In the September 2026 quarter, HealthCare Global booked revenue of Rs 733.7 crore against Rs 649.5 crore in the same quarter last year, a rise of 13.0%.

Jupiter Life Line Results Snapshot

Jupiter Life Line’s Q2 FY27 top line stood at Rs 467.0 crore, versus Rs 404.9 crore in Q2 FY26, a rise of 15.3%.

KIMS Results Snapshot

KIMS reported Q2 FY27 revenue of Rs 1,363 crore, compared with Rs 964.9 crore a year earlier, a rise of 41.3%. Net profit rose 3.6% to Rs 74.6 crore from Rs 72.0 crore. Operating margin expanded to 21.7% from 21.6% a year ago. Earnings per share for the quarter rose to Rs 1.79 from Rs 1.67.

Narayana Hrudayalaya Results Snapshot

In the September 2026 quarter, Narayana Hrudayalaya booked revenue of Rs 2,896 crore against Rs 1,668 crore in the same quarter last year, a rise of 73.6%. Net profit rose 16.5% to Rs 301.1 crore from Rs 258.5 crore. Earnings per share for the quarter rose to Rs 14.82 from Rs 12.72.

Occupancy, revenue per bed and new beds shape earnings, so profit can differ from revenue in a single quarter, so profit can look different from revenue in a single quarter. That is why a mid-cap hospital stock comparison works best when revenue and profit are read together across two or three quarters. Used this way, a mid-cap hospital stocks compared review becomes a map of the sector rather than a price list. When you compare mid-cap hospital stocks after each result season, track how operating margin changes from one quarter to the next.

Mid-Cap Hospital Stocks Compared Two at a Time: Three Pairings

Readers rarely want a five-way table and nothing else, so here are three head-to-head reads drawn from the same data. Use them as a quick way to compare mid-cap hospital stocks two at a time.

Rainbow Children vs HealthCare Global

Rainbow focuses on children and women care, while HCG focuses on cancer care. Rainbow Children is about 1.5 times the size of HealthCare Global by market capitalisation, at Rs 13,136 crore against Rs 8,589 crore. On price to earnings, Rainbow Children carries the lower multiple at 44.00 against 394.01 for HealthCare Global. Rainbow Children reports the higher return on equity, at 17.05% against 4.25% for HealthCare Global. Two specialist chains with different patient needs, so read margins next to valuation.

KIMS vs Narayana Hrudayalaya

KIMS runs a southern regional network, while Narayana Hrudayalaya runs a heart care led national network. On price to earnings, Narayana Hrudayalaya carries the lower multiple at 43.72 against 155.09 for KIMS. Narayana Hrudayalaya reports the higher return on equity, at 17.17% against 5.40% for KIMS. In Q2 FY27, Narayana Hrudayalaya grew revenue faster, at 73.6% year on year against 41.3% for KIMS. Two regional and national networks differ in expansion pace.

Jupiter Life Line vs KIMS

Jupiter Life Line runs multi-speciality hospitals in western India, while KIMS expands across southern states. KIMS is about 3.3 times the size of Jupiter Life Line by market capitalisation, at Rs 30,549 crore against Rs 9,353 crore. Jupiter Life Line reports the higher return on equity, at 11.43% against 5.40% for KIMS. In Q2 FY27, KIMS grew revenue faster, at 41.3% year on year against 15.3% for Jupiter Life Line. Two multi-speciality operators in different regions, so compare returns together.

Best Mid-Cap Hospital Stocks for Each Type of Investor

Which of the best mid-cap hospital stocks is right for you depends on your priorities, so the table below lists the leader on each measure instead of crowning one name. Any mid-cap hospital stocks compared table can mislead if you stop at one row, because each hospital chain leads on a different measure.

If you care most about Start your research with The number
Lowest price to earnings Narayana Hrudayalaya 43.72
Highest return on equity Narayana Hrudayalaya 17.17%
Highest dividend yield Rainbow Children 0.27%
Lowest price to book value Jupiter Life Line 5.74
Largest by market capitalisation Narayana Hrudayalaya Rs 37,565 crore
Fastest Q2 FY27 revenue growth Narayana Hrudayalaya 73.6%
Sharpest Q2 FY27 net profit rise Narayana Hrudayalaya 16.5%

No single name tops every row, which is exactly why a mid-cap hospital stock comparison helps. Margins, returns and valuation point to different companies, so decide what matters most to you before you rank the numbers.

What Is Driving Mid-Cap Hospital Companies Right Now?

Rising healthcare access, bed additions and insurance coverage keep mid-sized hospital chains in focus. Knowing what moves occupancy and bed additions helps you compare mid-cap hospital stocks with the right questions in mind.

Occupancy, revenue per bed and the case mix decide earnings, so chains in newer regions can show faster growth. A good mid-cap hospital stocks compared routine therefore tracks bed additions, occupancy and revenue per bed.

Risks to Weigh When You Compare Mid-Cap Hospital Stocks

Mid-Cap Hospital stocks depend on demand, input costs, policy and the wider market mood. Valuations differ by company, so read each filing for order, volume and margin commentary before you compare them. Every mid-cap hospital stock comparison has blind spots, and for this group the biggest is occupancy and bed additions.

Because bed additions, occupancy and revenue per bed drive these businesses, the most useful habit is to read the management commentary that comes with every result and note what is expected for the next quarter. Read together, the risk notes and the tables make this mid-cap hospital stocks compared guide a balanced starting point.

How to Compare Mid-Cap Hospital Stocks and Build a Shortlist

Start by deciding whether you want a specialist chain, a regional network or a national network, because each reads healthcare demand differently. Readers who track bed additions find the group easier to follow. Done step by step, this mid-cap hospital stocks compared routine becomes repeatable rather than a one-off exercise.

Then check valuation and returns, because growing hospital chains often carry premium multiples. A specialist chain next to a multi-speciality network shows how the model changes the profile. Keep the shortlist of best mid-cap hospital stocks short enough that you can actually follow each company’s quarterly results.

The Univest stock screener lets you filter mid-cap hospital stocks by market capitalisation, return on equity and price to earnings, and the app keeps live prices a tap away through the trading day. Come back to this mid-cap hospital stocks compared page after the next set of results to see which numbers have moved.

Check the Univest Screener for live mid-cap hospital stock data

Download the Univest iOS App or Univest Android App to track these mid-cap hospital stocks live.

Conclusion: Mid-Cap Hospital Stocks Compared at a Glance

This mid-cap hospital stocks compared review on price, valuation and Q2 FY27 results shows that no single name wins every measure. Narayana Hrudayalaya leads on both size and return on equity, though the others bring strengths of their own. Treat the mid-cap hospital stocks Q2 FY27 results and mid-cap hospital stocks valuation tables as a research starting point, then check the filings and speak to a SEBI-registered advisor before you invest. If you plan to compare mid-cap hospital stocks again next quarter, the same checklist of price to earnings, return on equity and operating margin will work.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Mid-Cap Hospital Stocks Compared

Which are the top mid-cap hospital stocks compared in this article?

Ans. The mid-cap hospital stocks compared in this article are Rainbow Children, HealthCare Global, Jupiter Life Line, KIMS and Narayana Hrudayalaya. They are checked on previous close, market capitalisation, price to earnings, price to book, return on equity and the latest quarterly results, so the group can be read in one sitting before you go deeper into any single company.

Which mid-cap hospital stock has the highest market capitalisation?

Ans. Among the five names, Narayana Hrudayalaya has the highest market capitalisation at Rs 37,565 crore. KIMS follows at Rs 30,549 crore. Market value changes with every price move, which means the ranking can shuffle, so look at the latest figure on the exchange.

Which of these mid-cap hospital stocks has the lowest price to earnings ratio?

Ans. On mid-cap hospital stocks valuation, Narayana Hrudayalaya has the lowest price to earnings ratio among these mid-cap hospital stocks at 43.72, based on the latest reported earnings. HealthCare Global sits at the other end at 394.01. Treat the lowest multiple as a place to start asking questions, because growth and business quality explain why investors pay more or less.

Which mid-cap hospital stock has the highest return on equity?

Ans. Narayana Hrudayalaya reports the highest return on equity in this group at 17.17%. In plain terms, return on equity tells you how hard shareholder funds are working. Read it across a few years and alongside debt, since a high ratio built on borrowing carries more risk.

How did mid-cap hospital stocks perform in Q2 FY27 results?

Ans. All of the five names have filed Q2 FY27 numbers in our data. Narayana Hrudayalaya recorded the fastest revenue growth at 73.6% year on year. Narayana Hrudayalaya showed the sharpest net profit rise at 16.5%. For mid-cap hospital stocks Q2 FY27 results, each filing on the exchange website carries the full detail behind these figures.

What are the main risks when you compare mid-cap hospital stocks?

Ans. Mid-Cap Hospital stocks depend on demand, input costs, policy and the wider market mood. Valuations differ by company, so read each filing for order, volume and margin commentary before you compare them. Keep an eye on bed additions, occupancy and revenue per bed.

Which metrics matter most when you compare mid-cap hospital stocks?

Ans. Revenue growth, operating margin, return on equity and debt to equity show operating strength and balance sheet room. Price to earnings shows how the market values each company. Read each filing for occupancy and bed commentary.

Which is the best mid-cap hospital stock to buy among these five?

Ans. The best mid-cap hospital stock depends on whether you want a specialist chain, a regional network or a national network, because the five names differ on all of these. On the numbers in this article, Narayana Hrudayalaya has the largest market capitalisation, the lowest price to earnings and the highest return on equity; Rainbow Children has the highest dividend yield. There is no clear winner across every measure, and nothing here is a recommendation. Let the tables narrow your list, confirm the numbers in the filings, and take advice from a SEBI-registered advisor before acting.



best mid-cap hospital stocks mid-cap hospital stocks compared mid-cap hospital stocks Q2 FY27 results mid-cap hospital stocks valuation
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply